# Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women

> **NCT01926158** · PHASE4 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 65 (actual)

## Conditions studied

- Hip Osteoarthritis

## Interventions

- **DRUG:** Denosumb
- **DRUG:** Placebo (for denosumab)

## Key facts

- **NCT ID:** NCT01926158
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2017-02-04
- **Final completion:** 2017-12-31
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2018-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01926158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01926158, "Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01926158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*